Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 8, 2024Frontiers in OncologyOpen Access

Frontline pembrolizumab monotherapy for metastatic non-small cell lung cancer with PD-L1 expression ≥50%: real-world outcomes in a US community oncology setting

View Full Paper
Ask AI
Bookmark
Share

Authors

SGShirish M. GadgeelPRPragya RaiSASrinivas Annavarapu

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Gadgeel et al. (2024) studied this question.

synapsesocial.com/papers/68e751c1b6db6435876ca238https://doi.org/10.3389/fonc.2024.1298603
View Full Paper
Ask AI
Bookmark
Share